Skip to main content

Table 1 Clinical characteristics of 18 patients in current study

From: Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?

Patient number Age Primary tumor FIGO stage Treatment for primary tumor Interval to bone metastasis (month) Site of bone metastasis Other site of metastasis Indication for orthopedic surgery Therapy for bone metastasis after surgery VAS (Pre/post-operative) ECOG (Pre/post-operative) Follow-up from orthopedic surgery (month) Status
1 59 EC IVA Chemo + RT 37 Sacrum   IP RT 6/1 3/1 10 DOD
2 68 EC IIIB Surg + Chemo 9 Pubic bone   IP CT 4/0 2/1 30 DOD
3 48 OC IIIC Chemo 22 Humerus   PF   5/1 2/1 8 DOD
4 75 OC IVB Chemo + RT at diagnosis Spine/T3   PF + SCC   4/1 4/2 6 DOD
5 51 EC IVB Surg + Chemo 19 Spine/T5 Lung SCC   6/2 3/3 13 DOD
6 63 OC IIIB RT 8 Spine/L2,3   IP   8/4 4/3 11 DOD
7 55 CC IIB Surg + Chemo 16 Femur   PF RT 4/3 4/2 15 DOD
8 55 EC IIIC Surg + Chemo + RT 26 Spine/L3   IP   4/1 3/2 28 DOD
9 45 EC IVB Chemo + RT at diagnosis Spine/T12 Liver SCC   7/2 3/4 3 DOD
10 55 EC IVA Surg + Chemo 16 Spine/L3 Liver IP   6/8 4/2 16 DOD
11 55 EC IIA Surg + Chemo 39 Femur   IP CT 6/1 3/1 34 NED
12 58 EC II Surg + Chemo 48 Acetabulum*/L1   IP   8/3 4/4 4 DOD
13 46 CC IIB Surg + Chemo + RT 25 Pubic bone   IP   7/3 1/2 6 DOD
14 35 CC IIIB Chemo + RT 14 Sacrum*/Ilium   IP RT 9/1 4/2 6 DOD
15 76 EC IIIB Surg + Chemo + RT 10 Spine/L3 Lung IP RT 6/4 3/4 4 DOD
16 56 EC IB Surg + Chemo 12 Femur   PF   4/1 4/2 24 AWD
17 46 CC IIIB Chemo + RT 20 Femur   PF CT 5/0 3/1 20 NED
18 47 CC IIB Surg + Chemo + RT 27 Humerus*/Ilium   PF RT 6/1 2/4 5 DOD
  1. AWD, alive with disease; CC, cervical cancer; Chemo, chemotherapy; DOD, died of disease; EC, endometrial carcinoma; EC, uterine leiomyosarcoma; IP, intractable pain; NED, no evidence of disease; OC, ovarian carcinoma; PF, pathological fractures; RT, radiotherapy; SCC, spinal cord compression; Surg, surgery.
  2. *Indicates the operation site.